BLFS
BioLife Solutions Inc
38.50$
-0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -293.6% | – | -25.7% | -65.7% | +5.0% | +326.6% | -17.2% | -19.5% | -110.0% | – | – | |
| – | -27.3% | -4.4% | +3.7% | -1.9% | -26.5% | -18.8% | -0.1% | -3.4% | -56.1% | +19.3% | -200.0% | – | |
| – | -8.6% | -25.8% | +41.0% | -38.9% | +100.6% | -61.2% | +41.1% | +0.8% | +19.9% | -32.1% | -200.0% | – | |
| – | – | -150.4% | – | -118.4% | – | -435.0% | – | -3,616.5% | – | – | – | – | |
| – | -34.4% | -63.7% | +179.5% | +12.0% | -4.7% | -83.5% | +896.0% | +89.4% | +338.5% | -98.8% | +0.0% | – | |
| – | +138.1% | -105.6% | +5,979.2% | -87.5% | – | -136.9% | +45.5% | -84.9% | – | -260.9% | -13.7% | – | |
| – | – | – | – | – | +26.2% | -27.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | +1,518.6% | -109.7% | -26.1% | +47.9% | +292.5% | -26.8% | -3.8% | -11.1% | -2.4% | +216.3% | -54.5% | – | |
| – | – | -135.3% | – | – | +3,266.0% | -139.9% | – | – | – | -387.2% | – | – | |
| – | – | -463.2% | – | -32.5% | -84.2% | +166.2% | +262.4% | -50.2% | -441.3% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.